84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]龔志兵,徐福東,黃淑霞,等.骨舒乳膏外用促進(jìn)全膝關(guān)節(jié)置換術(shù)后患肢瘀斑消退的臨床研究[J].中醫(yī)正骨,2020,32(04):9-14.
　GONG Zhibing,XU Fudong,HUANG Shuxia,et al.A clinical study of external application of Gushu(骨舒)cream in removing ecchymoses in affected limbs after total knee arthroplasty[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2020,32(04):9-14.
點(diǎn)擊復(fù)制

骨舒乳膏外用促進(jìn)全膝關(guān)節(jié)置換術(shù)后患肢瘀斑消退的臨床研究()
分享到：

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第32卷
期數(shù):
2020年04期
頁碼:
9-14
欄目:
臨床研究
出版日期:
2020-04-20

文章信息/Info

Title:
A clinical study of external application of Gushu(骨舒)cream in removing ecchymoses in affected limbs after total knee arthroplasty
作者:
龔志兵; 徐福東; 黃淑霞; 莊至坤; 張前進(jìn)
(泉州市正骨醫(yī)院,福建 泉州 362000)
Author(s):
GONG Zhibing; XU Fudong; HUANG Shuxia; ZHUANG Zhikun; ZHANG Qianjin Quanzhou Orthopedic Hospital; Quanzhou 362000; Fujian; China
Quanzhou Orthopedic Hospital,Quanzhou 362000,Fujian,China
關(guān)鍵詞:
關(guān)節(jié)成形術(shù); 置換; 膝;  瘀斑;  骨舒乳膏;  臨床試驗(yàn)
Keywords:
arthroplasty; replacement; knee;  ecchymosis;  Gushu cream;  clinical trial
摘要:
目的:觀察骨舒乳膏外用促進(jìn)全膝關(guān)節(jié)置換術(shù)(total knee arthroplasty,TKA)后患肢瘀斑消退的臨床療效和安全性。方法:選擇因膝關(guān)節(jié)非化膿性關(guān)節(jié)炎初次接受單側(cè)TKA,術(shù)后第3天患肢瘀斑面積>10 cm2的患者為研究對象。共納入60例患者,隨機(jī)分為2組,每組30例。常規(guī)治療組不針對瘀斑進(jìn)行干預(yù),骨舒乳膏組自術(shù)后第3天開始采用骨舒乳膏外用,每日2次,連續(xù)使用至術(shù)后第14天。選擇瘀斑面積和美國特種外科醫(yī)院(Hospital for Special Surgery,HSS)膝關(guān)節(jié)評分進(jìn)行療效評價,同時觀察治療期間不良反應(yīng)的發(fā)生情況。結(jié)果:①一般情況。骨舒乳膏組1例患者治療3 d后出現(xiàn)皮膚過敏反應(yīng)退出試驗(yàn),2例患者未嚴(yán)格遵醫(yī)囑使用骨舒乳膏退出試驗(yàn),1例患者資料記錄不完整予以剔除; 常規(guī)治療組1例患者術(shù)后第3天發(fā)生小腿肌間血栓,退出試驗(yàn),加大抗凝藥物劑量,治療1周后血栓消失; 2例患者資料記錄不完整予以剔除。②患肢瘀斑面積。時間因素和分組因素存在交互效應(yīng)(F=8.400,P=0.010)。2組患者瘀斑面積總體比較,組間差異有統(tǒng)計(jì)學(xué)意義,即存在分組效應(yīng)(F=6.180,P=0.020)。術(shù)后不同時間點(diǎn)瘀斑面積的差異有統(tǒng)計(jì)學(xué)意義,即存在時間效應(yīng)(F=271.790,P=0.000); 2組患者的瘀斑面積隨時間變化均呈先升高后降低的趨勢,但變化趨勢不完全一致[(3.00±2.00)cm2,(35.73±11.31)cm2,(51.89±11.90)cm2,(32.42±10.85)cm2,(10.39±5.25)cm2,F=179.628,P=0.000;(3.00±2.00)cm2,(36.33±11.13)cm2,(51.96±16.75)cm2,(40.74±12.72)cm2,(25.33±8.19)cm2,F=113.157,P=0.000]; 術(shù)后第1天、第3天、第5天,2組患者瘀斑面積的組間差異均無統(tǒng)計(jì)學(xué)意義(Z=-0.400,P=0.690; t=-0.190,P=0.850; t=-0.020,P=0.980); 術(shù)后第7天、第14天,骨舒乳膏組的瘀斑面積均小于常規(guī)治療組(t=-2.560,P=0.010; t=-7.880,P=0.000)。術(shù)后第14天時,按照瘀斑面積減少情況,骨舒乳膏組的療效優(yōu)于常規(guī)治療組((-overR)骨舒乳膏組=22.13,(-overR)常規(guī)治療組=31.69,Z=-2.665,P=0.008)。③HSS膝關(guān)節(jié)評分。時間因素和分組因素存在交互效應(yīng)(F=10.530,P=0.000)。2組患者HSS膝關(guān)節(jié)評分總體比較,組間差異有統(tǒng)計(jì)學(xué)意義,即存在分組效應(yīng)(F=5.520,P=0.020)。手術(shù)前后不同時間點(diǎn)HSS膝關(guān)節(jié)評分的差異有統(tǒng)計(jì)學(xué)意義,即存在時間效應(yīng)(F=372.220,P=0.000); 2組患者HSS膝關(guān)節(jié)評分隨時間變化均呈上升趨勢,但2組的上升趨勢不完全一致[(45.07±6.36)分,(57.08±4.02)分,(67.58±2.89)分,(76.00±4.08)分,F=254.592,P=0.000;(46.74±5.48)分,(58.70±4.69)分,(63.07±3.26)分,(70.37±5.12)分,F=129.816,P=0.000]; 術(shù)前及術(shù)后第3天,2組的HSS膝關(guān)節(jié)評分比較,組間差異均無統(tǒng)計(jì)學(xué)意義(t=-1.020,P=0.310; t=-1.350,P=0.180); 術(shù)后第7天和第14天,骨舒乳膏組的HSS膝關(guān)節(jié)評分均高于常規(guī)治療組(t=5.240,P=0.000; t=4.420,P=0.000)。術(shù)后第14天時,依據(jù)HSS膝關(guān)節(jié)評分進(jìn)行療效評定,骨舒乳膏組優(yōu)于常規(guī)治療組((-overR)骨舒乳膏組=22.38,(-overR)常規(guī)治療組=31.44,Z=-2.658,P=0.008)。④不良反應(yīng)。骨舒乳膏組1例患者因涂藥部位皮膚過敏退出試驗(yàn),停止用藥并以溫水擦洗處理后癥狀消失。常規(guī)治療組未出現(xiàn)不良反應(yīng)。2組患者的并發(fā)癥發(fā)生率比較,差異無統(tǒng)計(jì)學(xué)意義(P=0.491)。結(jié)論:TKA術(shù)后外用骨舒乳膏,可促進(jìn)患肢瘀斑消退,加速術(shù)后康復(fù),安全性高。
Abstract:
Objective:To observe the clinical curative effects and safety of external application of Gushu(骨舒,GS)cream in removing ecchymoses in affected limbs after total knee arthroplasty(TKA).Methods:Sixty patients received primary unilateral TKA for treatment of knee nonsuppurative arthritis and ecchymoses of >10 cm(2)were found in affected limbs at postoperative day 3.The patients were enrolled in the study and were randomly divided into conventional therapy group and GS cream group,30 cases in each group.The patients in conventional therapy group were not given any intervention in ecchymoses; while the patients in GS cream group were treated with external application of GS cream from postoperative day 3 to postoperative day 14,twice a day.The clinical curative effects were evaluated according to the area of ecchymoses and Hospital for Special Surgery(HSS)knee scores,and the incidence of adverse reactions were observed during the treatment period.Results:After 3-day treatment,four patients in GS cream group dropped out of the trial for allergic reactions in skin(1),failing to use GS cream strictly as required(2)and incomplete information(1)respectively.At postoperative day 3,one patient in conventional therapy group dropped out of the trial for surae intermuscular thrombus,and the thrombus disappeared after 1-week treatment with large doses of anticoagulants,besides,two patients were excluded for incomplete information.There was interaction between time factor and group factor in area of ecchymoses in affected limbs(F=8.400,P=0.010).There was statistical difference in the area of ecchymoses between the 2 groups in general,in other words,there was group effect(F=6.180,P=0.020).There was statistical difference in the area of ecchymoses between different timepoints after the surgery,in other words,there was time effect(F=271.790,P=0.000).The area of ecchymoses presented a time-dependent trend of increasing firstly and decreasing subsequently in the 2 groups,while the 2 groups were inconsistent with each other in the variation tendency(3.00+/-2.00,35.73+/-11.31,51.89+/-11.90,32.42+/-10.85,10.39+/-5.25 cm(2),F=179.628,P=0.000; 3.00+/-2.00,36.33+/-11.13,51.96+/-16.75,40.74+/-12.72,25.33+/-8.19 cm(2),F=113.157,P=0.000).There was no statistical difference in the area of ecchymoses between the 2 groups on postoperative day 1,3 and 5 respectively(Z=-0.400,P=0.690; t=-0.190,P=0.850; t=-0.020,P=0.980).The areas of ecchymoses were less in GS cream group compared to conventional therapy group on postoperative day 7 and 14 respectively(t=-2.560,P=0.010; t=-7.880,P=0.000).On postoperative day 14,the GS cream group surpassed the conventional therapy group in clinical curative effect according to the reduction of ecchymosis area((-overR)GS cream group=22.13,(-overR)conventional therapy group=31.69,Z=-2.665,P=0.008).There was interaction between time factor and group factor in HSS knee scores(F=10.530,P=0.000).There was statistical difference in HSS knee scores between the 2 groups in general,in other words,there was group effect(F=5.520,P=0.020).There was statistical difference in HSS knee scores between different timepoints before and after the surgery,in other words,there was time effect(F=372.220,P=0.000).The HSS knee scores presented a time-dependent increasing trend in the 2 groups,while the 2 groups were inconsistent with each other in the variation tendency(45.07+/-6.36,57.08+/-4.02,67.58+/-2.89,76.00+/-4.08 points,F=254.592,P=0.000; 46.74+/-5.48,58.70+/-4.69,63.07+/-3.26,70.37+/-5.12 points,F=129.816,P=0.000).There was no statistical difference in HSS knee scores between the 2 groups before the surgery and on postoperative day 3(t=-1.020,P=0.310; t=-1.350,P=0.180).The HSS knee scores were higher in GS cream group compared to conventional therapy group on postoperative day 7 and 14 respectively(t=5.240,P=0.000; t=4.420,P=0.000).On postoperative day 14,the GS cream group surpassed conventional therapy group in clinical curative effect according to the HSS knee scores((-overR)GS cream group=22.38,(-overR)conventional therapy group=31.44,Z=-2.658,P=0.008).One patient in GS cream group dropped out of the trial for allergic reactions in skin,and the symptoms disappeared after GS cream was suspended and the skin was swabbed with warm water.No adverse reactions were found in conventional therapy group.There was no statistical difference in complication incidences between the 2 groups(P=0.491).Conclusion:External application of GS cream can promote ecchymoses extinction and accelerate recovery after TKA with high safety.

參考文獻(xiàn)/References:

[1] 程開源,翁習(xí)生.2017膝關(guān)節(jié)重建術(shù)新進(jìn)展[J].中華骨與關(guān)節(jié)外科雜志,2017,10(6):530-535.
[2] SEHAT K R,EVANS R L,NEWMAN J H.Hidden blood loss following hip and knee arthroplasty.Correct management of blood loss should take hidden loss into account[J].J Bone Joint Surg Br,2004,86(4):561-565.
[3] LI N,LIU M,WANG D,et al.Comparison of complications in one-stage bilateral total knee arthroplasty with and without drainage[J].J Orthop Surg Res,2015,10:3.
[4] 李靂.TKA術(shù)后早期局部癥狀群規(guī)律探究[D].廣州:廣州中醫(yī)藥大學(xué),2015.
[5] WANG J,ZHU H L,SHI Z J,et al.The application of thromboelastography in understanding and management of ecchymosis after total knee arthroplasty[J].J Arthroplasty,2018,33(12):3754-3758.
[6] KANG Y,ZHANG Z J,FU M,et al.Blood transfusion and drainage catheter clamping are associated with ecchymosis formation at the surgical site after total knee arthroplasty:an analysis of 102 unilateral cases[J].Eur J Orthop Surg Traumatol,2013,23(2):219-224.
[7] ZHU S,QIAN W,JIANG C,et al.Enhanced recovery after surgery for hip and knee arthroplasty:a systematic review and meta-analysis[J].Postgrad Med J,2017,93(1106):736-742.
[8] 龔志兵,莊至坤,張煥堂,等.骨散外敷治療急性踝關(guān)節(jié)扭傷氣滯血瘀證的臨床研究[J].中醫(yī)正骨,2018,30(12):13-17.
[9] 鄭筱萸.中藥新藥臨床研究指導(dǎo)原則[M].北京:中國醫(yī)藥科技出版社,2002.
[10] 王李娜,程晉蘭,周曉蘭,等.正交設(shè)計(jì)法優(yōu)選骨舒乳膏基質(zhì)成分的配比[J].中國現(xiàn)代藥物應(yīng)用,2009,3(20):38-40.
[11] ELIZAVETA K,GIULIO A,GIUSEPPE F,et al.Knee scoring systems[M].Springer Berlin Heidelberg,2014:3373-3374.
[12] LEUNG K H,CHIU K Y,YAN C H,et al.Review article:venous thromboembolismafter total joint replacement[J].J Orthop Surg(Hong Kong),2013,21(3):351-360.
[13] 張華芳,陳梅,李成太.充氣止血帶個體化壓力值在膝關(guān)節(jié)置換手術(shù)中的應(yīng)用效果[J].安徽醫(yī)學(xué),2016,37(10):1292-1293.
[14] 任中華,李江濤,鄭志永.人工膝關(guān)節(jié)置換術(shù)后皮下瘀血形成與隱性失血量的相關(guān)性[J].廣東醫(yī)學(xué),2017,38(10):1558-1560.
[15] JUNG Y B,LEE Y S,LEE E Y,et al.Comparison of the modified subvastus and medial parapatellar approaches in total knee arthroplasty[J].Int Orthop,2009,33(2):419-423.
[16] 卿忠,劉淼.全膝關(guān)節(jié)置換術(shù)出血量分析及控制出血對策[J].中國骨與關(guān)節(jié)損傷雜志,2008,23(3):232-233.
[17] LI B,WEN Y,WU H,et al.The effect of tourniquet use on hidden blood loss in total knee arthroplasty[J].Int Orthop,2009,33(5):1263-1268.
[18] 于召龍.全膝關(guān)節(jié)置換術(shù)中有限使用止血帶的臨床效果觀察[D].濟(jì)南:山東大學(xué),2017.
[19] 康焱,傅明,盛璞義,等.人工全膝關(guān)節(jié)置換術(shù)后傷口周圍瘀斑形成的危險(xiǎn)因素分析[J].中華創(chuàng)傷骨科雜志,2010,12(12):1135-1138.
[20] DEMIRKALE I,TECIMEL O,SESEN H,et al.Nondrainage decreases blood transfusion need and infection rate in bilateral total knee arthroplasty[J].J Arthroplasty,2014,29(5):993-997.
[21] 袁義,章海均,張波,等.早期間斷夾閉引流管對全膝關(guān)節(jié)置換術(shù)后出血量影響的病例對照研究[J].中國骨傷,2019,32(1):60-63.
[22] WANG Z, SHEN X.The efficacy of combined intra-articular and intravenous tranexamic acid for blood loss in primary total knee arthroplasty:a meta-analysis[J].Medicine(Baltimore),2017,96(42):e8123.
[23] ZHANG L K,MA J X,KUANG M J,et al.The efficacy of tranexamic acid using oral administration in total knee arthroplasty:a systematic review and meta-analysis[J].J Orthop Surg Res,2017,12(1):159.
[24] ZHANG P,LI J F,WANG X.Combined versus single application of tranexamic acid in total knee and hip arthroplasty:a meta-analysis of randomized controlled trials[J].Int J Surg,2017,43:171-180.
[25] 國家衛(wèi)生計(jì)生委公益性行業(yè)科研專項(xiàng)《關(guān)節(jié)置換術(shù)安全性與效果評價》項(xiàng)目組,中華醫(yī)學(xué)會骨科學(xué)分會關(guān)節(jié)外科學(xué)組,中國醫(yī)療保健國際交流促進(jìn)會骨科分會關(guān)節(jié)外科委員會,等.中國髖、膝關(guān)節(jié)置換術(shù)加速康復(fù)——圍術(shù)期管理策略專家共識[J].中華骨與關(guān)節(jié)外科雜志,2016,9(1):1-9.
[26] 國家衛(wèi)生計(jì)生委公益性行業(yè)科研專項(xiàng)《關(guān)節(jié)置換術(shù)安全性與效果評價》項(xiàng)目組.中國髖、膝關(guān)節(jié)置換術(shù)圍術(shù)期抗纖溶藥序貫抗凝血藥應(yīng)用方案的專家共識[J].中華骨與關(guān)節(jié)外科雜志,2015,8(4):281-285.
[27] 高樂才,吳文元,魏金棟,等.術(shù)后抗凝對膝關(guān)節(jié)置換術(shù)后隱性失血影響的臨床觀察[J].河北醫(yī)藥,2013,35(6):880-882.
[28] ERSKINE J G,FRASER C,SIMPSON R,et al.Blood loss with knee joint replacement[J]. J R Coll Surg Edinb,1981,26(5):295-297.
[29] 陶坤,吳海山,李曉華,等.閉式引流在全膝關(guān)節(jié)置換術(shù)中的作用評價[J].中華外科雜志,2006,44(16):1111-1114.
[30] 鄭婧,張貴君,韋敏,等.五加皮藥材基原、化學(xué)成分及藥理作用研究進(jìn)展[J].遼寧中醫(yī)藥大學(xué)學(xué)報(bào),2015,17(8):104-107.
[31] 傅興圣,陳菲,劉訓(xùn)紅,等.大黃化學(xué)成分與藥理作用研究新進(jìn)展[J].中國新藥雜志,2011,20(16):1534-1538.
[32] 鄭勇鳳,王佳婧,傅超美,等.黃芩的化學(xué)成分與藥理作用研究進(jìn)展[J].中成藥,2016,38(1):141- 147.
[33] CHINNAM N,DADI P K,SABRI S A,et al.Dietary bioflavonoids inhibit escherichia coli ATP synthase in differential manner[J].Int J Biolo Macromol,2010,46(5):478-486.
[34] DAI B D,CAO Y Y,HUANG S,et al.Baicalein induces programmed cell death in Candida albicans[J].J Microbiol Biotechnol,2009,19(8):803-809.
[35] 鄺棗園,符林春,羅海燕,等.從受體角度探討黃芩苷對肺炎衣原體感染細(xì)胞的干預(yù)作用[J].廣州中醫(yī)藥大學(xué)學(xué)報(bào),2005,22(3):210-212.
[36] 孟祥樂,李紅偉,李顏,等.梔子化學(xué)成分及其藥理作用研究進(jìn)展[J].中國新藥雜志,2011,20(11): 959-967.
[37] 那莎,龍子江,王宗殿,等.梔子總皂苷對肝郁脾虛型慢性肝炎大鼠血液流變學(xué)的影響[J].江蘇中醫(yī)藥,2005,26(1):52-54.
[38] 林清,張建軍,李偉,等.五倍子與黃柏外用治療急性濕疹的配伍合理性研究[J].中華中醫(yī)藥雜志,2011,26(9):2126-2129.
[39] 李燕妮,徐東紅,代科科,等.復(fù)方黃柏液外用治療新生兒膿皰疹34例[J].河南中醫(yī),2014,34(10):1993.
[40] 張亞范,崔桂香,李輝.石膏黃柏外用治療關(guān)節(jié)扭傷106例療效觀察[J].青島醫(yī)藥衛(wèi)生,2004,36(3):208.
[41] 蔣燕萍,甘彥雄,嚴(yán)鑫,等.自然銅的研究進(jìn)展[J].中藥與臨床,2016,7(1):62-64.
[42] 檀龍顏,馬洪娜.骨碎補(bǔ)藥理作用的研究進(jìn)展[J].中國民族民間醫(yī)藥,2017,26(11):66-70.
[43] 蔣海峰,宿樹蘭,歐陽臻,等.乳香、沒藥提取物及其配伍對血小板聚集與抗凝血酶活性的影響[J].中國實(shí)驗(yàn)方劑學(xué)雜志,2011,17(19):160-165.
[44] 李東曉,鄧文龍.冰片促透作用研究進(jìn)展[J].中藥藥理與臨床,2007,23(1):87-88.

相似文獻(xiàn)/References:

[1]邢金明.切開復(fù)位鎖定鋼板內(nèi)固定術(shù)和人工半肩關(guān)節(jié)置換術(shù) 治療老年肱骨近端復(fù)雜骨折的對比研究[J].中醫(yī)正骨,2015,27(08):11.
　XING Jinming.A retrospective trial of open reduction and locking plate internal fixation versus artificial shoulder hemiarthroplasty for complicated proximal humeral fractures in old patients[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(04):11.
[2]趙云昌.人工股骨頭置換治療老年粉碎性股骨轉(zhuǎn)子間骨折[J].中醫(yī)正骨,2015,27(08):31.
[3]張明強(qiáng).生物型加長柄半髖關(guān)節(jié)置換術(shù)治療 高齡不穩(wěn)定股骨轉(zhuǎn)子間骨折療效觀察[J].中醫(yī)正骨,2015,27(02):56.
[4]蔡云仙.圍手術(shù)期耳穴按壓聯(lián)合平衡針療法 在全膝關(guān)節(jié)置換術(shù)后鎮(zhèn)痛中的應(yīng)用[J].中醫(yī)正骨,2015,27(06):41.
[5]喻長純,楊明路,王戰(zhàn)朝.不同手術(shù)方式治療脛骨平臺骨折畸形愈合的體會[J].中醫(yī)正骨,2015,27(03):37.
[6]魏瑄,宋樹春,王金良.術(shù)前精確測量和評估在全髖關(guān)節(jié)置換治療 成人發(fā)育性髖關(guān)節(jié)發(fā)育不良繼發(fā)骨關(guān)節(jié)炎中的價值[J].中醫(yī)正骨,2015,27(01):30.
[7]鮑榮華,陳曉東,王國平,等.Wagner Cone生物型假體置換結(jié)合經(jīng)股骨轉(zhuǎn)子下橫形截骨 治療CroweⅣ型成人發(fā)育性髖關(guān)節(jié)發(fā)育不良[J].中醫(yī)正骨,2015,27(01):33.
[8]喻長純,楊明路,王戰(zhàn)朝.同期髕骨脫位矯正術(shù)聯(lián)合全膝關(guān)節(jié)置換術(shù)治療 晚期膝骨關(guān)節(jié)炎合并習(xí)慣性髕骨脫位[J].中醫(yī)正骨,2015,27(01):41.
[9]武理國,沈軍,傅國海,等.人工肱骨頭置換治療老年肱骨近端復(fù)雜骨折[J].中醫(yī)正骨,2013,25(10):70.
[10]李國梁,韓廣普,閆國強(qiáng),等.紅花化瘀湯薰蒸聯(lián)合理筋手法 在膝骨關(guān)節(jié)炎全膝關(guān)節(jié)置換術(shù)后康復(fù)中的應(yīng)用[J].中醫(yī)正骨,2013,25(12):31.
　Li Guoliang*,Han Guangpu,Yan Guoqiang,et al.Clinical application of HONGHUAHUAYU decoctions steaming combined with sinew adjusting manipulation in the postoperative rehabilitation of total knee arthroplasty in patients with knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(04):31.
[11]樊慶陽,任凱晶.定制3D打印切模輔助全膝關(guān)節(jié)置換術(shù)治療 膝骨關(guān)節(jié)炎合并股骨干骨折畸形愈合[J].中醫(yī)正骨,2015,27(11):37.
[12]李翰林,童培建.利福平聯(lián)合用藥配合保留假體清創(chuàng)治療 人工關(guān)節(jié)置換術(shù)后早期感染及低毒性感染[J].中醫(yī)正骨,2015,27(09):56.
[13]劉曉雅,孫永強(qiáng),劉國杰.主動快速康復(fù)鍛煉對全膝關(guān)節(jié)置換術(shù)后關(guān)節(jié)活動度的影響[J].中醫(yī)正骨,2015,27(09):73.
[14]張維平,康兩期,陳衛(wèi),等.全髖關(guān)節(jié)置換術(shù)圍手術(shù)期隱性失血的研究進(jìn)展[J].中醫(yī)正骨,2015,27(08):61.
[15]宋兵華,孫俊英,倪增良,等.全膝關(guān)節(jié)置換術(shù)前CT測量股骨后髁角的臨床意義[J].中醫(yī)正骨,2015,27(07):38.
[16]王金良,孫京濤,李玲,等.骨水泥聯(lián)合螺釘修復(fù)全膝關(guān)節(jié)置換術(shù)中 脛骨平臺內(nèi)側(cè)骨缺損[J].中醫(yī)正骨,2015,27(12):55.
[17]徐偉鋒,葉健,吳連國.強(qiáng)骨飲對骨質(zhì)疏松性股骨頸骨折患者全髖關(guān)節(jié)置換術(shù)后 血清骨代謝生化指標(biāo)和骨密度的影響[J].中醫(yī)正骨,2015,27(02):12.
　XU Weifeng,YE Jian,WU Lianguo.Effect of Qianggu Yin(強(qiáng)骨飲,QGY)on serum bone metabolism indexes and bone density after total hip arthroplasty in patients with osteoporotic femoral neck fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(04):12.
[18]張榮,王健.人工全膝關(guān)節(jié)置換術(shù)的圍手術(shù)期心理護(hù)理[J].中醫(yī)正骨,2015,27(05):77.
[19]齊志遠(yuǎn),陳秀民,王在斌,等.桃紅四物加黃芪湯預(yù)防人工髖膝關(guān)節(jié)置換術(shù)后 下肢深靜脈血栓形成[J].中醫(yī)正骨,2015,27(03):71.
[20]陸吳超,季衛(wèi)鋒,馬鎮(zhèn)川.關(guān)節(jié)鏡下清創(chuàng)后持續(xù)灌洗聯(lián)合中藥口服治療 全膝關(guān)節(jié)置換術(shù)后急性期感染[J].中醫(yī)正骨,2015,27(01):51.

備注/Memo

備注/Memo:
(收稿日期:2020-01-09 本文編輯:李曉樂)通訊作者:徐福東 E-mail:[email protected]
更新日期/Last Update: 2020-07-31